These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14613314)

  • 1. Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist.
    Xu Y; Mayhugh D; Saeed A; Wang X; Thompson RC; Dominianni SJ; Kauffman RF; Singh J; Bean JS; Bensch WR; Barr RJ; Osborne J; Montrose-Rafizadeh C; Zink RW; Yumibe NP; Huang N; Luffer-Atlas D; Rungta D; Maise DE; Mantlo NB
    J Med Chem; 2003 Nov; 46(24):5121-4. PubMed ID: 14613314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Singh JP; Kauffman R; Bensch W; Wang G; McClelland P; Bean J; Montrose C; Mantlo N; Wagle A
    Mol Pharmacol; 2005 Sep; 68(3):763-8. PubMed ID: 15933217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
    Xu Y; Rito CJ; Etgen GJ; Ardecky RJ; Bean JS; Bensch WR; Bosley JR; Broderick CL; Brooks DA; Dominianni SJ; Hahn PJ; Liu S; Mais DE; Montrose-Rafizadeh C; Ogilvie KM; Oldham BA; Peters M; Rungta DK; Shuker AJ; Stephenson GA; Tripp AE; Wilson SB; Winneroski LL; Zink R; Kauffman RF; McCarthy JR
    J Med Chem; 2004 May; 47(10):2422-5. PubMed ID: 15115385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.
    Rudolph J; Chen L; Majumdar D; Bullock WH; Burns M; Claus T; Dela Cruz FE; Daly M; Ehrgott FJ; Johnson JS; Livingston JN; Schoenleber RW; Shapiro J; Yang L; Tsutsumi M; Ma X
    J Med Chem; 2007 Mar; 50(5):984-1000. PubMed ID: 17274610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators.
    Nomura M; Tanase T; Ide T; Tsunoda M; Suzuki M; Uchiki H; Murakami K; Miyachi H
    J Med Chem; 2003 Aug; 46(17):3581-99. PubMed ID: 12904063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose levels and modifies lipoprotein profiles in KK-Ay mice.
    Kuwabara K; Murakami K; Todo M; Aoki T; Asaki T; Murai M; Yano J
    J Pharmacol Exp Ther; 2004 Jun; 309(3):970-7. PubMed ID: 14982965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists.
    Yamazaki Y; Abe K; Toma T; Nishikawa M; Ozawa H; Okuda A; Araki T; Oda S; Inoue K; Shibuya K; Staels B; Fruchart JC
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4689-93. PubMed ID: 17553678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and identification of [1,2,4]thiadiazole derivatives as a new series of potent and orally active dual agonists of peroxisome proliferator-activated receptors alpha and delta.
    Shen L; Zhang Y; Wang A; Sieber-McMaster E; Chen X; Pelton P; Xu JZ; Yang M; Zhu P; Zhou L; Reuman M; Hu Z; Russell R; Gibbs AC; Ross H; Demarest K; Murray WV; Kuo GH
    J Med Chem; 2007 Aug; 50(16):3954-63. PubMed ID: 17608467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synthetic farnesoid X receptor (FXR) agonist promotes cholesterol lowering in models of dyslipidemia.
    Evans MJ; Mahaney PE; Borges-Marcucci L; Lai K; Wang S; Krueger JA; Gardell SJ; Huard C; Martinez R; Vlasuk GP; Harnish DC
    Am J Physiol Gastrointest Liver Physiol; 2009 Mar; 296(3):G543-52. PubMed ID: 19136377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.
    Ebdrup S; Pettersson I; Rasmussen HB; Deussen HJ; Frost Jensen A; Mortensen SB; Fleckner J; Pridal L; Nygaard L; Sauerberg P
    J Med Chem; 2003 Apr; 46(8):1306-17. PubMed ID: 12672231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large dimeric ligands with favorable pharmacokinetic properties and peroxisome proliferator-activated receptor agonist activity in vitro and in vivo.
    Sauerberg P; Bury PS; Mogensen JP; Deussen HJ; Pettersson I; Fleckner J; Nehlin J; Frederiksen KS; Albrektsen T; Din N; Svensson LA; Ynddal L; Wulff EM; Jeppesen L
    J Med Chem; 2003 Nov; 46(23):4883-94. PubMed ID: 14584939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
    Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
    J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eigenvalue analysis of peroxisome proliferator-activated receptor gamma agonists.
    Liao C; Xie A; Shi L; Zhou J; Lu X
    J Chem Inf Comput Sci; 2004; 44(1):230-8. PubMed ID: 14741032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of a human-specific peroxisome proliferater-activated receptor alpha (PPARalpha) agonist in dogs.
    Nagasawa M; Ide T; Suzuki M; Tsunoda M; Akasaka Y; Okazaki T; Mochizuki T; Murakami K
    Biochem Pharmacol; 2004 Jun; 67(11):2057-69. PubMed ID: 15135303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and structure-activity relationship studies of novel 6,7-locked-[7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta]-2,4,6-trienoic acids.
    Michellys PY; Ardecky RJ; Chen JH; D'Arrigo J; Grese TA; Karanewsky DS; Leibowitz MD; Liu S; Mais DA; Mapes CM; Montrose-Rafizadeh C; Ogilvie KM; Reifel-Miller A; Rungta D; Thompson AW; Tyhonas JS; Boehm MF
    J Med Chem; 2003 Sep; 46(19):4087-103. PubMed ID: 12954061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents.
    Sierra ML; Beneton V; Boullay AB; Boyer T; Brewster AG; Donche F; Forest MC; Fouchet MH; Gellibert FJ; Grillot DA; Lambert MH; Laroze A; Le Grumelec C; Linget JM; Montana VG; Nguyen VL; Nicodème E; Patel V; Penfornis A; Pineau O; Pohin D; Potvain F; Poulain G; Ruault CB; Saunders M; Toum J; Xu HE; Xu RX; Pianetti PM
    J Med Chem; 2007 Feb; 50(4):685-95. PubMed ID: 17243659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A short and efficient synthesis of the pharmacological research tool GW501516 for the peroxisome proliferator-activated receptor delta.
    Wei ZL; Kozikowski AP
    J Org Chem; 2003 Nov; 68(23):9116-8. PubMed ID: 14604391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design of potent retinoid X receptor alpha agonists.
    Haffner CD; Lenhard JM; Miller AB; McDougald DL; Dwornik K; Ittoop OR; Gampe RT; Xu HE; Blanchard S; Montana VG; Consler TG; Bledsoe RK; Ayscue A; Croom D
    J Med Chem; 2004 Apr; 47(8):2010-29. PubMed ID: 15056000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities.
    Doebber TW; Kelly LJ; Zhou G; Meurer R; Biswas C; Li Y; Wu MS; Ippolito MC; Chao YS; Wang PR; Wright SD; Moller DE; Berger JP
    Biochem Biophys Res Commun; 2004 May; 318(2):323-8. PubMed ID: 15120604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.